RecruitingNCT05848271

Natural History Study of Patients with HPDL Mutations

A Patient Registry and Natural History Study of Patients with Biallelic HPDL Mutations


Sponsor

University of California, San Diego

Enrollment

50 participants

Start Date

May 18, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study uses medical records that allow retrospective data extraction of clinical manifestation to assess the natural history of HPDL mutations


Eligibility

Inclusion Criteria6

  • Any individuals diagnosed with HPDL variants
  • Clinical diagnosis can include:
  • HPDL-related hereditary spastic paraplegia (HSP)
  • HPDL-related neonatal mitochondrial encephalopathy
  • Spastic paraplegia -83 (SPG83)
  • Neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities (NEDSWMA)

Exclusion Criteria2

  • Any known genetic abnormality (other than HPDL mutation)
  • Any condition that, in the opinion of the Site Investigator, could put the participant at undue risk and/or would ultimately prevent the completion of study procedures

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPatient Registry

Participants who have been diagnosed with HPDL mutations will be enrolled to patient registry.

OTHERDry blood spots sampling

Dry blood splots require 500nl of blood.


Locations(1)

Eun Hae Lee

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05848271


Related Trials